Skip to main content
. Author manuscript; available in PMC: 2017 Dec 11.
Published in final edited form as: Cancer Res. 2013 Dec 18;74(3):787–796. doi: 10.1158/0008-5472.CAN-13-1423

Figure 3.

Figure 3

CSA inhibits PDH activity in glioblastoma cells. A, CSA and l-cystine lead to a dose-dependent inhibition of PDH activity in U251 (P < 0.007). B, CSA (P < 0.005) but not l-cystine (P = 0.67) inhibits PDH activity in the non-CDO–expressing cell line T98G. C, dichloroacetate (DCA; 1 mmol/L) increases PDH activity in U251 (P = 0.003), which is abrogated with the pretreatment of CSA (1 mmol/L; P = 0.117). Results are representative of at least three independent experiments.